{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:07:24Z","timestamp":1769969244928,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["DEC-2013\/09\/B\/NZ3\/02327"],"award-info":[{"award-number":["DEC-2013\/09\/B\/NZ3\/02327"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association Espoir Isere Contre Le Cancer"},{"name":"association Gefluc Grenoble Dauphin\u00e9-Savoie"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.nano.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T17:00:38Z","timestamp":1526576438000},"page":"1853-1865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Leukocytes and drug-resistant cancer cells are targets for intracellular delivery by adenoviral dodecahedron"],"prefix":"10.1016","volume":"14","author":[{"given":"Marta","family":"Jedynak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Laurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patryk","family":"Dolega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Podsiadla-Bialoskorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Szurgot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga","family":"Chroboczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Szolajska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2018.05.001_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2018.05.001_bb0010","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2018.05.001_bb0015","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2018.05.001_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/btm2.10049","article-title":"Virus-like particles: next generation nanoparticles for therapeutic delivery","volume":"2","author":"Rahovie","year":"2017","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2018.05.001_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha \u03bd beta 3 and alpha \u03bd beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nano.2018.05.001_bb0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.virol.2004.01.015","article-title":"Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron","volume":"321","author":"Viv\u00e8s","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.nano.2018.05.001_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2007.09.026","article-title":"Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle","volume":"371","author":"Fender","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.nano.2018.05.001_bb0040","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI6869","article-title":"The role of alpha v integrins during angiogenesis: insights into potential mechanisms of action and clinical development","volume":"103","author":"Eliceiri","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2018.05.001_bb0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nbt0697-542","article-title":"Alpha v integrins as receptors for tumor targeting by circulating ligands","volume":"15","author":"Pasqualini","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2018.05.001_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nbt0197-52","article-title":"Adenovirus dodecahedron, a new vector for human gene transfer","volume":"15","author":"Fender","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2018.05.001_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jgm.862","article-title":"Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors","volume":"8","author":"Garcel","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.nano.2018.05.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5030589","article-title":"The use of adenovirus dodecahedron in the delivery of an enzymatic activity in the cell","volume":"2016","author":"Sumarheni","year":"2016","journal-title":"Biotechnol Res Int"},{"key":"10.1016\/j.nano.2018.05.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005569","article-title":"Adenovirus dodecahedron, as a drug delivery vector","volume":"4","author":"Zochowska","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.05.001_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nano.2014.07.009","article-title":"Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma","volume":"11","author":"Zochowska","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2018.05.001_bb0075","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1016\/j.vaccine.2013.07.021","article-title":"Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform","volume":"31","author":"Szurgot","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.05.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111762","article-title":"Efficient uptake of blood-borne BK and JC polyomavirus-like particles in endothelial cells of liver sinusoids and renal vasa recta","volume":"9","author":"Simon-Santamaria","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.05.001_bb0085","first-page":"383","article-title":"Human sarcoma cell lines MES-SA and MES-SA\/Dx5 as a model for multidrug resistance modulators screening","volume":"25","author":"Wesolowska","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nano.2018.05.001_bb0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12033-015-9850-9","article-title":"Adenovirus dodecahedron, a VLP, can be purified by size exclusion chromatography instead of time-consuming sucrose density gradient centrifugation","volume":"57","author":"Szurgot","year":"2015","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.nano.2018.05.001_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/156800912799277421","article-title":"Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier","volume":"12","author":"Caraglia","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.nano.2018.05.001_bb0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/bc0402888","article-title":"Chemical conjugation of heterologous proteins on the surface of cowpea mosaic virus","volume":"15","author":"Chatterji","year":"2004","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2018.05.001_bb0105","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/bc050147l","article-title":"Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold","volume":"16","author":"Sen Gupta","year":"2005","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2018.05.001_bb0110","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.18632\/oncotarget.2182","article-title":"Medical treatment of orthotopic glioblastoma with transferrin conjugated nanoparticles encapsulating zoledronic acid","volume":"5","author":"Porru","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.nano.2018.05.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035187","article-title":"TumorHoPe: a database of tumor homing peptides","volume":"7","author":"Kapoor","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.05.001_bb0120","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"Wang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.05.001_bb0125","first-page":"66","article-title":"Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents","volume":"21","author":"Hunt","year":"2010","journal-title":"J Biomol Tech"},{"key":"10.1016\/j.nano.2018.05.001_bb0130","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/JVI.02819-06","article-title":"Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver","volume":"81","author":"Stone","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.05.001_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymthe.2006.01.003","article-title":"Adenovirus type 5 interactions with human blood cells may compromise systemic delivery","volume":"14","author":"Lyons","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2018.05.001_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2018.05.001_bb0145","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/JVI.69.4.2257-2263.1995","article-title":"Upregulation of integrins alpha vbeta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery","volume":"69","author":"Huang","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.05.001_bb0150","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/JVI.70.7.4502-4508.1996","article-title":"Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells","volume":"70","author":"Huang","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2018.05.001_bb0155","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/bi5013782","article-title":"Ligand recognition specificity of leukocyte integrin \u03b1M\u03b22 (Mac-1, CD11b\/CD18) and its functional consequences","volume":"54","author":"Podolnikova","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.nano.2018.05.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046075","article-title":"The structural basis for the integrity of adenovirus Ad3 dodecahedron. J","volume":"7","author":"Szolajska","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.05.001_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2018.05.001_bb0170","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1039\/c1nr10580a","article-title":"Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism","volume":"3","author":"Shen","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2018.05.001_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10717540902937562","article-title":"Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells","volume":"16","author":"Kang","year":"2009","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2018.05.001_bb0180","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.18632\/oncotarget.6013","article-title":"Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines","volume":"7","author":"Perillo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nano.2018.05.001_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2018.05.001_bb0190","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11095-007-9277-5","article-title":"Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells","volume":"24","author":"Mohajer","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2018.05.001_bb0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1432-1033.1991.tb15840.x","article-title":"Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells","volume":"196","author":"Frezard","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nano.2018.05.001_bb0200","first-page":"4091","article-title":"Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA","volume":"45","author":"Harker","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2018.05.001_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2014.00041","article-title":"Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function","volume":"4","author":"Sharom","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2018.05.001_bb0210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/cyto.990130811","article-title":"Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry","volume":"13","author":"Belloc","year":"1992","journal-title":"Cytometry"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T03:38:03Z","timestamp":1604288283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418300923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1549963418300923"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2018.05.001","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocytes and drug-resistant cancer cells are targets for intracellular delivery by adenoviral dodecahedron","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}